Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Cash & Current Investments came in at $168.6 million in Q2 2026, up 107.64% on a YoY basis from $81.2 million in Q2 2025, and up 14.31% quarter-over-quarter from $147.5 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Cash & Current Investments for 5 consecutive years, with $168.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Current Investments rose 107.64% year-over-year to $168.6 million; the trailing twelve-month figure through Jun 2026 stood at $168.6 million (up 107.64% YoY), and the FY2025 full-year result was $174.6 million, up 47.34% from the prior year.
- Cash & Current Investments climbed to $168.6 million in Q2 2026 per FTRE's latest filing, from $147.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $174.6 million in Q4 2025 and bottomed at $81.2 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $120.7 million across 5 years, with a median of $113.2 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Cash & Current Investments plunged 35.66% in 2025, then jumped 107.64% in 2026.
- Over 5 years, Cash & Current Investments stood at $112.0 million in 2022, then declined by 3.04% to $108.6 million in 2023, then grew by 9.12% to $118.5 million in 2024, then soared by 47.34% to $174.6 million in 2025, then fell by 3.44% to $168.6 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $168.6 million, $147.5 million, and $174.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.08 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 192.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 425.88 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 84.54 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 4.40 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168.60 Mn |
| Mar 31, 2026 | 147.50 Mn |
| Dec 31, 2025 | 174.60 Mn |
| Sep 30, 2025 | 131.30 Mn |
| Jun 30, 2025 | 81.20 Mn |
| Mar 31, 2025 | 101.60 Mn |
| Dec 31, 2024 | 118.50 Mn |
| Sep 30, 2024 | 105.30 Mn |
| Jun 30, 2024 | 126.20 Mn |
| Mar 31, 2024 | 92.80 Mn |
| Dec 31, 2023 | 108.60 Mn |
| Sep 30, 2023 | 107.50 Mn |
| Jun 30, 2023 | 114.30 Mn |
| Dec 31, 2022 | 112.00 Mn |